
Nelnet (NNI) has wrapped up FY 2025 with fourth quarter revenue of US$348.3 million and basic EPS of US$1.60, anchored by net income of US$57.8 million as investors weigh that against a trailing twelve month EPS of US$11.79 on US$1.68 billion of revenue. Over the past two reported years in this data set, quarterly revenue has ranged from US$289.7 million in Q3 2024 to US$516.1 million in Q2 2025, while basic EPS has moved between US$0.07 and US$4.97. This gives a clearer view of how both the top line and EPS have shifted through the cycle. With trailing net margin reported higher than a year ago, the latest print focuses on how much of that revenue is being converted into profit and what that might indicate about the durability of those margins.
See our full analysis for Nelnet.With the headline numbers set, the next step is to line them up against the widely followed stories around Nelnet's growth, profitability and risk to see which narratives hold up and which ones the latest results start to question.
Curious how numbers become stories that shape markets? Explore Community Narratives
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Nelnet's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
With mixed signals on growth, margins and valuation, do you feel the story is leaning more positive or cautious right now? Take a closer look at the data, weigh the trade off between risks and rewards for yourself, and use 2 key rewards and 2 important warning signs to see how those factors line up in one place.
Nelnet pairs a 25.5% TTM net margin with slow 0.3% revenue growth, a share price far above DCF fair value, and debt that cash flow does not cover well.
If stretched valuation signals and weaker debt coverage are giving you pause, take a moment to compare that profile against solid balance sheet and fundamentals stocks screener (39 results), built to highlight companies with healthier financial footing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com